Clinical Trials Browser

Glioma × Sorafenib × Sarcoma × Clear all

NCT00597493 2013-06-24

Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM

Phase 2 Completed

32 enrolled 9 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma